Akademiliv

Sahlgrenska akademins nyheter

På Svenska
University of Gothenburg Logotype
  • News
  • Notices
  • Calendar
  • Grants
  • About Akademiliv

In memory of Arvid Carlsson (1923-2018)

26 July, 2018

Arvid Carlsson

IN MEMORY. Arvid Carlsson, professor of pharmacology at Sahlgrenska Academy, University of Gothenburg, has passed away, at the age of 95. Arvid Carlsson was awarded The Nobel Prize in Physiology or Medicine for his pioneering research on the signal substances of the brain.

Agneta Holmäng, dean, Sahlgrenska Academy at University of Gothenburg:
“Sahlgrenska Academy misses both a very good friend and co-worker, but also an outstanding researcher. Arvid Carlsson is the originator of several major discoveries that led to dramatic improvements in quality of life for millions of patients with neurological and psychiatric disorders.”

Eva Wiberg, Vice-Chancellor, University of Gothenburg:
“It is an honor for us at University of Gothenburg to have had such a successful researcher and co-worker as Arvid Carlsson with us. He has made a fantastic contribution to science and in his work inspired students and the research community in both Sweden and all over the world.”

Dopamine involved in everything

Arvid Carlsson, in a podcast from Sahlgrenska Academy, University of Gothenburg, 2016:
“Dopamine is involved in everything that happens in our brain, all the important functions.”

By acquiring knowledge on how substances such as dopamine and serotonin can be influenced, Arvid Carlsson and his research team were part of developing medicines that increase the mobility of patients with Parkinson’s disease and help improve the lives of those with schizophrenia. In addition, their research laid the foundation for modern medicines against anxiety and depression.

Arvid Carlsson was one of the Gothenburg researchers who set the stage for close cooperation with the pharmaceutical company Astra Hassle, later AstraZeneca – a collaboration that led to internationally renowned medicines like Seloken, Zelmid, Plendil and Losec.

Scientific breakthrough

Arvid Carlsson was, in his early career, able to demonstrate that dopamine acts as a message carrier molecule in the brain, and that a shortage of this substance gives rise to impaired motor skills in the case of Parkinson’s disease, for example.

In clinical studies, an agent which is converted into dopamine in the brain, DOPA, was found to lead to massively improved motor skills in many severely disabled patients. For a long time this agent has been the most effective treatment available for Parkinson’s disease.

Arvid Carlsson’s studies into the function of dopamine led to another scientific breakthrough in 1963. He discovered that the medications which ease the symptoms of schizophrenia and other psychotic diseases reduse the influence of dopamine in the brain.

Treatment revolution

Arvid Carlsson and his colleagues were also the first people to realise that selective amplification of the signal substance serotonin is an effective and fairly gentle way of treating depression. Prozac, which revolutionised the treatment of depression and anxiety diseases, is based on this mode of action.

Arvid Carlsson

The observation that it is possible to influence the symptoms of Parkinson’s disease and psychosis by modifying dopamine activity has been of crucial importance to our understanding of these diseases. But even more important is the fact that these studies have made it clear for the first time that it is actually possible to influence the function of the brain by modulating the signal substances that deal with communication between the neurons by means of medicines.

Later research on pharmacological therapy for many neurological and psychiatric diseases is to alarge extent based on this strategy demonstrated by Arvid Carlsson.

In 2016 Arvid Carlsson was interviewed in a podcast at his faculty, Sahlgrenska Academy, about his ongoing research and all the awards he had received during his long career:

“I couldn’t have received so many prizes if I had got the Nobel Prize earlier, because then they stop giving other prizes.”

“The award that you get from patients, compared to all the awards I have received, is much more important.”

  • Podcast with Arvid Carlsson 2015 (Swedish)
  • Podcast with Arvid Carlsson 2016 (English)
  • About The Nobel Prize in Physiology or Medicine 2000 (English, French, German, Swedish)

 

TEXT: MARGARETA GUSTAFSSON KUBISTA
PHOTO: JOHAN WINGBORG

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

By: Akademiliv redaktion
Tagged With: institutionen för neurovetenskap och fysiologi

Add your own events in the Akademiliv Calendar

Collected links regarding the war in Ukraine

The novel coronavirus – University-wide information on the Staff Portal

Read up-tp-date information regarding how effects of the pandemic are handled at the university.

We are building at Medicinareberget

You will now find comprehensive information on construction projects that affect the Sahlgrenska Academy in the Staff Portal.

Lunch menus

Café & restaurang Anatomen

Gastronomen på SU

Lunchen.nu

Lyktan lunchservering

Lustgården på Änggårdsbacken

Café Anne Dahl

More news

Let our innovation advisers help you with your idea

17 May, 2022

INTERACTION. Together with several colleagues, Marcus Lind is working to be granted a patent for an idea that could lead to a new way to treat …  

New launch of national information on animal experimentation

17 May, 2022

RESEARCH CONDITIONS. A new version of djurforsok.info was recently launched. The site is a collaboration between the Swedish Research Council and …  

Yiwen Jiang won the University’s first 3MT competition

16 May, 2022

INTERACTION. As part of the Science Festival, a Three-Minute Thesis (3MT) winner was selected on Friday afternoon. In this competition, doctoral …  

Agnes Wold gives answers about the corona in the podcast Akademiliv (in Swedish)

13 May, 2022

Now you can hear the recording of the podcast Akademiliv from the live performance on stage in Nordstan during the Science Festival in …  

A great day for the faculty as Bo Håkansson becomes an honorary doctor

13 May, 2022

ACADEMIC CEREMONY. At the celebration lecture before his conferment of an honorary doctorate, Bo Håkansson described his 45-year journey in the …  

First in-person master’s thesis project fair in health and technology

13 May, 2022

STUDENTS. For the first time, the master’s thesis project fair for health and technology students was held on site at Medicinareberget. A concept …  

GPCC strengthens its research to achieve the goals for the new centre period

13 May, 2022

INTER-ACTION. The Centre for Person-centred Care GPCC is now starting up new research projects and new collaborations. The projects will …  

Science, heathcare, and loneliness in Anja Smits’ debut novel

11 May, 2022

BOOK RELEASE. Anja Smits, professor of neurology at the University of Gothenburg, has debuted as a fiction writer. Though both science and the …  

Pär Matsson speaks at the OligoNova Network-meeting Photo: Johan Wingborg

OligoNova Network gathers research on drugs of the future

10 May, 2022

INTERACTION. Yet another important step for the development of Life Science in the Gothenburg region was taken recently, when leading …  

The 2022 Assar Gabrielsson Foundation prize-winners selected

10 May, 2022

PRIZE. The Assar Gabrielsson Foundation has named Angela Molinaro as a prize-winner in the basic scientific research category and Emilia Alfonzo …  

More news...

Sahlgrenska Academy

© University of Gothenburg
PO-Box 100, S-405 30 Gothenburg, Sweden
Phone: 00 46 31 786 0000

About the website

Elin Lindström is editor for Akademiliv.
Please feel free to send your ideas and comments to akademiliv@gu.se

Sign up for the Akademiliv newsletter:

Send you tips to Akademiliv

Do you have a suggestion for news, grants, seminars or an education?
Send an email to Elin Lindström Claessen